Jiange Qiu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes.
Journal: Diabetes
Published: April 09, 2025
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.
Journal: Current cancer drug targets
Published: December 18, 2023
Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis.
Journal: Genes & diseases
Published: November 23, 2023
Complementary roles of EP2 and EP4 receptors in malignant glioma.
Journal: British journal of pharmacology
Published: October 24, 2022
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population.
Journal: Nature communications
Published: October 02, 2021
Olfactory Function, Genetic Predisposition, and Cognitive Performance in Chinese Adults.
Journal: Current Alzheimer research
Published: September 28, 2021
Genetic evidence for facial variation being a composite phenotype of cranial variation and facial soft tissue thickness.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: September 16, 2021
Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
Journal: British journal of pharmacology
Published: October 02, 2018
Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
Journal: Scientific reports
Published: March 09, 2017
Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?
Journal: Trends in cancer
Published: August 31, 2016
Last Updated: 09/26/2026